Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 6/20 | 0.54 |
| ▸ | BACE2 | Q9Y5Z0 | 3/20 | 0.54 |
| ▸ | OPRD1 | P41143 | 7/20 | 0.48 |
| ▸ | CCKAR | P32238 | 3/20 | 0.46 |
| ▸ | CCKBR | P32239 | 3/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | ENPEP | Q07075 | 3/20 | 0.46 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30915528 | 0.90 | NAALAD2 (0.54) | BACE1BACE2ENPEP | |
| SCHEMBL30931574 | 0.90 | ENPEP (0.52) | OPRD1ENPEP | |
| SCHEMBL31345046 | 0.90 | BACE1 (0.53) | BACE1BACE2 | |
| SCHEMBL31680262 | 0.88 | BACE1 (0.47) | BACE1BACE2OPRD1CCKARCCKBR | |
| SCHEMBL30753845 | 0.87 | NAALAD2 (0.51) | BACE1BACE2ENPEPOPRM1 | |
| SCHEMBL30719918 | 0.87 | BACE1 (0.44) | BACE1BACE2PTPN1 | |
| SCHEMBL30688994 | 0.86 | NAALAD2 (0.52) | BACE1BACE2ENPEPOPRM1 | |
| SCHEMBL29881615 | 0.85 | PTPN1 (0.47) | BACE1BACE2PTPN1 | |
| SCHEMBL30937421 | 0.85 | NAALAD2 (0.47) | BACE1BACE2 | |
| SCHEMBL30676241 | 0.85 | NAALAD2 (0.47) | BACE1BACE2OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4642492-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | Hangzhou Seehe Biotechnology Co., Ltd (CN) | 2025-11-05 | — | — | EP | claimed |
| WO-2024240173-A1 | AN ANTIBODY-DRUG CONJUGATE HAVING TWO OR MORE FUNCTIONAL SMALL MOLECULE COMPOUNDS FOR ENHANCED TREATMENT OF REFRACTORY DISEASES | HANGZHOU SEEHE BIOTECHNOLOGY CO., LTD (CN) | 2024-11-28 | — | — | WO | claimed |